Cibc Private Wealth Group, LLC Axsome Therapeutics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $52.7 Billion
- Q4 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 16,214 shares of AXSM stock, worth $1.93 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,214
Previous 16,214
-0.0%
Holding current value
$1.93 Million
Previous $1.46 Million
5.84%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding AXSM
# of Institutions
351Shares Held
35.7MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$483 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$465 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$393 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$175 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$165 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.11B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...